Posts tagged “Inspire”

September 8, 2011

Drutz to chair Gentris board

Gentris The company said Dr. David J. Drutz has been elected chairman, and entrepreneur and accountant Tim Gupton has joined the board.

June 30, 2011

Merck to close former Inspire HQ in Raleigh, cut 51 workers

Merck The drug giant recently purchased Raleigh-based Inspire Pharmaceuticals. In a notice filed with the state, the expected closure of Inspire's offices is made official.

May 17, 2011

Merck wraps up $430M Inspire deal, will close Raleigh HQ

Merck Some company executives will be leaving the eye drug firm as it is absorbed by the pharmaceutical giant.

Updated May 10, 2011

Inspire reports $17.6M quarterly loss after restructuring

Inspire eye drug fails Phase II trials The Raleigh-based pharmaceutical firm, which is in the process of being acquired by drug giant Merck, says losses increased nearly $3 million from a year ago.

Updated April 6, 2011

Merck's $430M buy triggers Inspire stock frenzy

Merck Merck will pay $5 a share for Inspire. Both boards and a major Inspire investor have already approved the deal. Inspire's shares collapsed in January after a failed drug trial.

March 18, 2011

Tech briefs: Inspire Pharmaceuticals, Dex One, Nexxus Lighting, NC toll road devices

Tech Briefs Inspire offers bonuses; Dex One seeks feedback on executive pay; Lowes to sell Nexxus LED lighting; NC toll roll RFID devices clear tests.

February 17, 2011

Inspire drops lung drug, cuts 65 positions

Inspire Pharmaceuticals Inspire Pharmaceuticals said Thursday that it is laying off 65 people, or 27 percent of its work force related to the drug's development.

January 4, 2011

Analyst cuts Inspire after failed clinical trial

Inspire Shares in the Raleigh-based pharmaceutical firm plunged Monday on news of a failure for its drug targeting cystic fibrosis.

Updated January 3, 2011

Meltdown: Inspire Pharmaceutical shares down 59%

Inspire The company, which just moved to Raleigh, says its candidate for treatment of cystic fibrosis fails to meet efficacy goals in Phase III clinical trial.

December 13, 2010

$1.25M payday for Inspire - Dry eye drug launches in Japan

Inspire The Durham-based pharmaceutical firm's partner in Japan receives approval to launch Diquas. That news triggers a milestone payment plus future royalties.

Updated November 4, 2010

Inspire cuts losses, beats Street expectations

Inspire The Durham-based pharmaceutical firm loses far less than forecast - 9 cents per share rather than 14 cents as expected.

Updated August 25, 2010

Inspire, Allergan revise licensing agreement for eye drugs

Inspire The Durham-based firm regains control of failed drug candidate Prolacria. Inspire also will receive smaller royalties from Allegran for sales of eye drug Restasis.

Member Center

The Skinny: A Blog by Rick Smith

Videos

 
  • [VIDEO]

    Japan's tech titans post record losses

  • [VIDEO]

    FBI study reveals cyber crime trends

  • [VIDEO]

    Community collaborates for Triangle Wiki

  • [VIDEO]

    Video game conference is strictly…

  • [VIDEO]

    Re-program speed dial before Saturday

  • [VIDEO]

    Red Hat exec talks about company's $1B…

  • [VIDEO]

    Bloomberg: Cisco sets sights on video…

  • [VIDEO]

    Duke doc's group discovers cancer link